Skip to main content

Table 6 Subgroup Analysis Major Outcomes

From: Comparison of anticoagulated versus non-anticoagulated patients with intra-aortic balloon pumps

  Heparin group (n = 43) Non-heparin group (n = 45) p value
Composite endpoint of bleeding 11 (25.6) 8 (17.8) 0.44
Major access site bleeding 1 (2.3) 2 (4.4) 1
Minor access site bleeding 3 (6.9) 2 (4.4) 1
Major non-access site bleeding 2 (4.7) 3 (6.7) 1
Minor non-access site bleeding 5 (11.6) 1 (2.3) 0.12
Composite endpoint of thrombosis events 2 (4.7) 3 (6.7) 1
Limb ischemia 1 (2.3) 1 (2.2) 1
Device thrombosis 0 0 1
VTE 1 (2.3) 1 (2.2) 1
Ischemic stroke 0 1 (2.2) 1
  1. All values are n(%)